Report : Asia Pacific Smart Pills Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Application (Capsule Endoscopy, Drug Delivery, and Patient Monitoring), Disease Indication (Gastrointestinal Diseases, Neurological Disorders, Cancer, Inherited Disorders, and Other Disease Indications), and End User (Hospitals and Clinics, Research Institutes, and Home Healthcare)
Capsule Endoscopy segment has the Largest Share of Application in the Asia Pacific Smart Pills Market during 2019–2028
According to our latest study on “Asia Pacific Smart Pills Market Forecast to 2028 – COVID-19 Impact and Analysis – by “Application, Disease Indication and End User ” the market is projected to reach US$ 1,156.22 million by 2028 from US$ 488.75 million in 2021; it is expected to grow at a CAGR of 13.1% from 2021 to 2028. The report highlights trends prevailing in the market, and the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as rising demand for minimally invasive surgical and increase in the strategic collaboration & partnerships on smart pills. However, high cost of smart pill is hamper the market growth.
The smart pills market, based on application, has been segmented into capsule endoscopy, drug delivery and patient monitoring. The capsule endoscopy segment is likely to hold the largest share of the market in 2021. Moreover, the drug delivery segment is anticipated to register the highest CAGR in the market during the forecast period of 2021 to 2028. This is mainly because smart pill with environmental sensors, a feedback algorithm and a drug release mechanism can lead to smart drug delivery systems, supportive technologies resulting in accounting high CAGR during the forecast period.
Medtronic; PENTAX Medical; Olympus Corporation; Otsuka Holdings Co., Ltd. IntroMedic Co., Ltd; JINSHAN Science & Technology ; RF Co., Ltd are among the leading companies in the Asia Pacific smart pills market .The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.
The market for Asia Pacific smart pills market is segmented into application, disease indication and end user. Based on application, the market is segmented into capsule endoscopy, drug delivery, and patient monitoring. The capsule endoscopy sub segmented into small bowel video capsule endoscopy, colon capsule endoscopy, controllable capsule endoscopy, storable capsule endoscope and other capsule endoscopy. Based on disease indication, the Asia Pacific smart pills market is segmented into gastrointestinal diseases, neurological disorders, cancer, inherited disorders, and other disease indications. Based on end user, the Asia Pacific smart pills market is segmented into hospitals and clinics, research institutes, and home healthcare. By Country, the Asia Pacific smart pills market is segmented into Japan, China, India, South Korea, Australia and Rest of APAC.
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email Id: firstname.lastname@example.org